Xeris Biopharma (XERS) Earnings Date, Estimates & Call Transcripts

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)

Free XERS Stock Alerts

$1.78

-0.02 (-1.11%)

(As of 04/17/2024 ET)

Compare

Upcoming Earnings Date: May. 14Estimated
Actual EPS (Mar. 6): -$0.10 Missed By -$0.01
Consensus EPS (Mar. 6): -$0.09

Read Call Transcript

Listen to Call

Earnings Per Share Revenue

XERS Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

XERS Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Ad Paradigm Press

Bitcoin Rockets To Record High But Buy THIS Instead

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.

Xeris Biopharma Analyst EPS Estimates

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate	Company Guidance
Q1 2024	2	($0.14)	($0.11)	($0.13)
Q2 2024	2	($0.11)	($0.11)	($0.11)
Q3 2024	2	($0.13)	($0.08)	($0.11)
Q4 2024	2	($0.13)	($0.07)	($0.10)
FY 2024	8	($0.51)	($0.37)		($0.44)

XERS Earnings Date and Information

Xeris Biopharma last released its earnings data on March 6th, 2024. The reported ($0.10) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.09) by $0.01. The business had revenue of $44.39 million for the quarter, compared to analysts' expectations of $45.50 million. Xeris Biopharma has generated ($0.45) earnings per share over the last year (($0.45) diluted earnings per share). Earnings for Xeris Biopharma are expected to grow in the coming year, from ($0.38) to ($0.17) per share. Xeris Biopharma has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 14th, 2024 based off prior year's report dates.

Xeris Biopharma Earnings History by Quarter

Time Frame

Start Date

End Date

Export to Excel

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue
5/14/2024 Estimated)	-	-	-	-	-	-	-
3/6/2024	Q4 2023	($0.09)	($0.10)	($0.01)	($0.10)	$45.50 million	$44.39 million
11/9/2023	Q3 2023	($0.12)	($0.09)	+$0.03	($0.09)	$40.93 million	$48.32 million
8/8/2023	Q2 2023	($0.13)	($0.14)	($0.01)	($0.14)	$34.84 million	$38.01 million
5/9/2023	Q1 2023	($0.17)	($0.12)	+$0.05	($0.12)	$30.77 million	$33.20 million
3/8/2023	Q4 2022	($0.16)	($0.10)	+$0.06	($0.10)	$31.04 million	$33.14 million
11/9/2022	Q3 2022	($0.17)	($0.14)	+$0.03	($0.12)	$29.12 million	$29.73 million
Get the Latest News and Ratings for XERS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Xeris Biopharma and its competitors with MarketBeat's FREE daily newsletter.
8/10/2022	Q2 2022	($0.23)	($0.19)	+$0.04	($0.19)	$25.53 million	$25.31 million
5/11/2022	Q1 2022	($0.24)	($0.25)	($0.01)	($0.25)	$22.92 million	$22.07 million
3/10/2022	Q4 2021	($0.21)	($0.42)	($0.21)	($0.42)	$20.72 million	$21.43 million
11/9/2021	Q3	($0.37)	($0.39)	($0.02)	($0.33)	$10.43 million	$11.04 million
8/5/2021	Q2 2021	($0.30)	($0.41)	($0.11)	($0.41)	$9.95 million	$8.84 million
5/13/2021	Q1 2021	($0.31)	($0.30)	+$0.01	($0.30)	$7.57 million	$8.05 million

Xeris Biopharma Earnings - Frequently Asked Questions

When is Xeris Biopharma's earnings date?: Xeris Biopharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 14th, 2024 based off last year's report dates. Learn more on XERS's earnings history.
Did Xeris Biopharma beat their earnings estimates last quarter?: In the previous quarter, Xeris Biopharma (NASDAQ:XERS) missed the analysts' consensus estimate of ($0.09) by $0.01 with a reported earnings per share (EPS) of ($0.10). Learn more on analysts' earnings estimate vs. XERS's actual earnings.
How can I listen to Xeris Biopharma's earnings conference call?: The conference call for Xeris Biopharma's latest earnings report can be listened to online. Listen to Conference Call

How can I read Xeris Biopharma's conference call transcript?: The conference call transcript for Xeris Biopharma's latest earnings report can be read online. Read Transcript
How much revenue does Xeris Biopharma generate each year?: Xeris Biopharma (NASDAQ:XERS) has a recorded annual revenue of $163.91 million.
How much profit does Xeris Biopharma generate each year?: Xeris Biopharma (NASDAQ:XERS) has a recorded net income of -$62.26 million. XERS has generated -$0.45 earnings per share over the last four quarters.
What is Xeris Biopharma's EPS forecast for next year?: Xeris Biopharma's earnings are expected to grow from ($0.38) per share to ($0.17) per share in the next year.

More Earnings Resources from MarketBeat

Related Companies:

Earnings Tools:

Earnings By Country:

Latest Articles:

This page (NASDAQ:XERS) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Xeris Biopharma (XERS) Earnings Date, Estimates & Call Transcripts

XERS Earnings Estimates and Actuals by Quarter

XERS Estimated and Actual Revenue by Quarter

Xeris Biopharma Analyst EPS Estimates

XERS Earnings Date and Information

Xeris Biopharma Earnings History by Quarter

Xeris Biopharma Earnings - Frequently Asked Questions

More Earnings Resources from MarketBeat

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Xeris Biopharma (XERS) Earnings Date, Estimates & Call Transcripts

Earnings Summary

XERS Earnings Estimates and Actuals by Quarter

XERS Estimated and Actual Revenue by Quarter

Xeris Biopharma Analyst EPS Estimates

XERS Earnings Date and Information

Xeris Biopharma Earnings History by Quarter

Xeris Biopharma Earnings - Frequently Asked Questions

More Earnings Resources from MarketBeat